Testing for COVID-19 is technical, expensive and complicated -- particularly in Alaska, with its remote, far-flung communities and overlapping systems of tribal and private health care. That ...
When the plot was written for Sunnyvale's Cepheid, it was a classic tale of turning swords into plowshares. Founded in 1996, the fledgling biotech company took fast new methods of DNA analysis ...
For much of last year, the coronavirus crept, undetected, across eastern Democratic Republic of Congo. Test samples had to be sent more than 1,500 kilometres from remote hospitals to the capital ...
Despite last week's hit, Cepheid (CPHD) has been a stock market darling over the past 4 years, as it has taken advantage of a huge opportunity in the MRSA screening market. MRSA is a "staph" germ that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback